Arvinas Cash from Investing (Quarterly) Trends

Arvinas Inc (ARVN)

33.16 +0.92 (+2.85%) USD | NASDAQ | May 31, 16:00

33.14 -0.02 (-0.06%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-127.80M
December 31, 2023	-53.70M
September 30, 2023	70.00M
June 30, 2023	48.60M
March 31, 2023	138.60M
December 31, 2022	19.40M
September 30, 2022	105.80M
June 30, 2022	109.00M
March 31, 2022	8.60M
December 31, 2021	-115.60M
September 30, 2021	-741.10M
June 30, 2021	-249.10M
March 31, 2021	-207.80M

Date	Value
December 31, 2020	56.91M
September 30, 2020	59.28M
June 30, 2020	5.610M
March 31, 2020	42.49M
December 31, 2019	-95.43M
September 30, 2019	-31.81M
June 30, 2019	-4.228M
March 31, 2019	38.37M
December 31, 2018	-101.86M
September 30, 2018	11.80M
June 30, 2018	-45.26M
March 31, 2018	-44.34M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-741.10M

Minimum

Sep 2021

138.60M

Maximum

Mar 2023

-48.11M

Average

7.105M

Median

Cash from Investing (Quarterly) Benchmarks

Pfizer Inc	1.732B
Bristol-Myers Squibb Co	-19.62B
Alnylam Pharmaceuticals Inc	-67.62M
Rhythm Pharmaceuticals Inc	30.05M
IDEAYA Biosciences Inc	-353.97M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-97.50M
Cash from Financing (Quarterly)	1.60M
Free Cash Flow	-356.00M
Free Cash Flow Per Share (Quarterly)	-1.361
Free Cash Flow to Equity (Quarterly)	-97.50M
Free Cash Flow to Firm (Quarterly)	-97.60M
Free Cash Flow Yield	-17.86%